2012
DOI: 10.1007/s13238-012-2056-z
|View full text |Cite
|
Sign up to set email alerts
|

Structural basis of heparan sulfate-specific degradation by heparinase III

Abstract: Heparinase III (HepIII) is a 73-kDa polysaccharide lyase (PL) that degrades the heparan sulfate (HS) polysaccharides at sulfate-rare regions, which are important co-factors for a vast array of functional distinct proteins including the well-characterized antithrombin and the FGF/FGFR signal transduction system. It functions in cleaving metazoan heparan sulfate (HS) and providing carbon, nitrogen and sulfate sources for host microorganisms. It has long been used to deduce the structure of HS and heparin motifs;… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
16
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 23 publications
(17 citation statements)
references
References 53 publications
1
16
0
Order By: Relevance
“…To determine whether HSPGs are necessary for EVT invasion and migration, Matrigel-based invasion assays and scratch-wound migration assays were performed using a well-established EVT line, HTR8/SVneo (henceforth referred to as HTR8 EVTs). Cells were treated with different concentrations of unfractionated heparin (which competitively inhibits heparan sulfate chains interacting with ligands 24 ) or heparinase III (which cleaves heparan sulfate chains from HSPGs 25 ) during assays. Compared to controls, approximately 35% less cells invaded through Matrigel following exposure to 10 µg/ml or 100 µg/ml unfractionated heparin (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…To determine whether HSPGs are necessary for EVT invasion and migration, Matrigel-based invasion assays and scratch-wound migration assays were performed using a well-established EVT line, HTR8/SVneo (henceforth referred to as HTR8 EVTs). Cells were treated with different concentrations of unfractionated heparin (which competitively inhibits heparan sulfate chains interacting with ligands 24 ) or heparinase III (which cleaves heparan sulfate chains from HSPGs 25 ) during assays. Compared to controls, approximately 35% less cells invaded through Matrigel following exposure to 10 µg/ml or 100 µg/ml unfractionated heparin (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…The active centers of exoHep and Hepase II partially overlap, indicating that their catalytic mechanism might have some features in common. As shown in this study, the residues His 337 , Tyr 390 and His 555 of exoHep corresponding to the three key residues His 202 , Tyr 257 and His 406 of Hepase II 22 play key roles in the catalytic mechanism of exoHep, indicating that similar to other lyases, including Hepases I, II and III, exolytic Hepases catalyze the degradation of HP via a catalytic mechanism in which Tyr-His acts as the Brønsted base and acid 19,22,23 . However, unlike in the case of the His 337 to Ala mutation that completely destroyed the ability of exoHep to cleave the tetrasaccharide ΔUA2S1-4GlcNS6S1-4IdoA2S1-4GlcNS6S ( Supplementary Fig.…”
Section: Discussionmentioning
confidence: 59%
“…Hepase II adopts a topology similar to Hepase III and has no selectivity for certain GlcA/IdoA or IdoA2S/GlcA2S structures 18,21,22 . All Hepases share similar catalytic mechanisms in which Tyr-His acts as a Brønsted base and acid 19,22,23 .…”
Section: Introductionmentioning
confidence: 99%
“…Their catalytic residues and global architecture of their active sites are similar, suggesting similarity of their catalytic mechanisms ( Figure 4, Table S2). The catalytic tyrosine is strictly conserved, Tyr314 in PL12 (PDB code 4FNV [27 ]), Tyr258 in PL17 (PDB code 4OJZ [25 ]) and Tyr299 in PL23 (PDB code 3VSM [28 ]) (Figure 5b,c). Histidine, which plays the role of a Brønsted base during anti elimination, is present in some PL12 enzymes (e.g.…”
Section: Alginate and Gag Lyasesmentioning
confidence: 99%
“…Heparinase III from P. heparinus (PDB code 4MMH) has an open conformation with the neutralizer Asn240 positioned 10 Å from the catalytic Tyr294, an arrangement clearly incompatible with catalysis [29]. B. thetaiotaomicron heparinase III (PDB code 4FNV) has a more compact conformation [27 ]. The first PL23 structure also displays an open conformation where the neutralizer Asn236 is apparently too far from the catalytic residues [28 ] (Figure 5c).…”
Section: Alginate and Gag Lyasesmentioning
confidence: 99%